cbdMD Inc (YCBD) - Total Liabilities

Latest as of June 2025: $3.78 Million USD

Based on the latest financial reports, cbdMD Inc (YCBD) has total liabilities worth $3.78 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does cbdMD Inc generate cash to assess how effectively this company generates cash.

cbdMD Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how cbdMD Inc's total liabilities have evolved over time, based on quarterly financial data. Check YCBD asset resilience ratio to evaluate the company's liquid asset resilience ratio.

cbdMD Inc Competitors by Total Liabilities

The table below lists competitors of cbdMD Inc ranked by their total liabilities.

Company Country Total Liabilities
Altheora SA
PA:ALORA
France €23.25 Million
Avenir Telecom S.A
PA:AVT
France €17.85 Million
Syncona Limited
LSE:SYNC
UK GBX13.77 Million
Cell Impact AB
ST:CI
Sweden Skr29.21 Million
Granada Gold Mine Inc
V:GGM
Canada CA$14.53 Million
Oscar Mitra Sukses Sejahtera Tbk PT
JK:OLIV
Indonesia Rp7.89 Billion
Luminar Technologies
NASDAQ:LAZR
USA $505.08 Million
Interoil Exploration and Production ASA
OL:IOX
Norway Nkr88.37 Million

Liability Composition Analysis (2015–2024)

This chart breaks down cbdMD Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see YCBD market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.62 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how cbdMD Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for cbdMD Inc (2015–2024)

The table below shows the annual total liabilities of cbdMD Inc from 2015 to 2024.

Year Total Liabilities Change
2024-09-30 $8.62 Million +20.30%
2023-09-30 $7.16 Million -23.52%
2022-09-30 $9.37 Million -56.91%
2021-09-30 $21.74 Million -31.33%
2020-09-30 $31.66 Million -44.37%
2019-09-30 $56.91 Million +5600.21%
2018-09-30 $998.46K -48.01%
2017-09-30 $1.92 Million +0.23%
2016-09-30 $1.92 Million +251.31%
2015-09-30 $545.41K --

About cbdMD Inc

NYSE MKT:YCBD USA Drug Manufacturers - Specialty & Generic
Market Cap
$8.13 Million
Market Cap Rank
#27811 Global
#5491 in USA
Share Price
$0.91
Change (1 day)
+7.36%
52-Week Range
$0.47 - $2.27
All Time High
$304.65
About

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more